Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze SUPN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate SUPN investment potential.

What is SUPN stock price today?

Get real-time SUPN stock price, historical data, and price charts on Financhill. Track SUPN performance with our advanced analysis tools.

Is SUPN a good investment?

Evaluate SUPN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy SUPN stock?

To buy SUPN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of SUPN?

View detailed market capitalization data and company valuation metrics for SUPN on our comprehensive analysis page.

What is the P/E ratio of SUPN?

Use our fundamental analysis tools to view SUPN P/E ratio and compare valuation metrics with industry peers.

What are SUPN earnings?

View SUPN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Supernus Pharmaceuticals, Inc. Stock Predictions

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Buy

SUPN
Supernus Pharmaceuticals, Inc.

Last Price:

$51.14

Seasonality Move:

6.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet America's Newest $1B Unicorn

Supernus Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Supernus Pharmaceuticals, Inc. has on average historically risen by 22.2% based on the past 13 years of stock performance.
Supernus Pharmaceuticals, Inc. has risen higher in 10 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 76.92%
Is Supernus Pharmaceuticals, Inc. Stock Undervalued?

The current Supernus Pharmaceuticals, Inc. [SUPN] share price is $51.11. The Score for SUPN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
SUPN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Supernus Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Supernus Pharmaceuticals, Inc. has on average historically risen by 22.2% based on the past 13 years of stock performance.

Supernus Pharmaceuticals, Inc. Stock Rating

Buy

Supernus Pharmaceuticals, Inc. (SUPN) is a Buy

Is Supernus Pharmaceuticals, Inc. overpriced?

Supernus Pharmaceuticals, Inc. has risen higher in 10 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 76.92%

Supernus Pharmaceuticals, Inc. Stock Price History

Is SUPN stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

supernus.com

52-Week Data

52-Week High:

57.65

52-Week Low:

29.16

Prediction Charts

Market Cap:

2.9B

Price in USD:

51.11

Volume:

1.2M

Beta:

1.08

Technical Analysis

SMA50:

48.32

SMA100:

47.77

SMA200:

40.54

52-Wk Change:

34.29%

Stock Predictions

Is Supernus Pharmaceuticals, Inc. stock public?

Yes, Supernus Pharmaceuticals, Inc. is a publicly traded company.
What is the Supernus Pharmaceuticals, Inc. stock quote today?

The Supernus Pharmaceuticals, Inc. stock price is 51.11 USD today.
How to buy Supernus Pharmaceuticals, Inc. stock online?

You can buy Supernus Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-19	48.90	51.48	52.11	47.98
Dec-22	51.37	51.50	51.66	50.61
Dec-23	51.47	51.71	52.28	51.25
Dec-24	52.21	51.77	52.30	51.01
Dec-26	51.65	51.57	52.02	51.29
Dec-29	51.55	51.25	51.75	51.14
Dec-30	51.32	49.89	51.41	49.69
Dec-31	50.00	49.70	50.10	49.32
Jan-2	49.70	49.47	50.05	48.37
Jan-5	49.25	49.40	49.77	48.27
Jan-6	49.18	49.26	49.54	47.80
Jan-7	50.15	51.24	51.42	49.90
Jan-8	51.32	51.17	51.83	50.45
Jan-9	52.00	51.11	52.39	50.45

Supernus Pharmaceuticals, Inc. Earnings

Supernus Pharmaceuticals, Inc. Earnings Report: Per Share Supernus Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Supernus Pharmaceuticals, Inc. Forecast Revenue Growth

Supernus Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and an increase next year of $1.37 per share.

* Supernus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.